乌帕替尼半水合物
Upadacitinib hemihydrate
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Upadacitinib hemihydrate
CAS2050057-56-0
FormulaC34H40F6N12O3
MW778.75
Security information
Product details

Upadacitinib, also known as ABT-494, is a potent and selective JAK inhibitors in development for rheumatoid arthritis. ABT-494 is approximately 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. ABT-494 demonstrates efficacy in rat arthritis models. Preliminary evidence suggests that compared to tofacitinib, ABT-494 may spare Jak2 and Jak3 dependent signaling.

Related literature
Related
Sorry, no related items
History
Upadacitinib hemihydrate
(2S,3R)-(+)-3-Isopropyl-2-phenyl-3,4-dihydro-2H-pyrimido[2,1-b][1,3]benzothiazole
Olcegepant hydrochloride (Synonyms: BIBN-4096 hydrochloride; BIBN4096BS hydrochloride)
Cetrorelix Acetate
Eldelumab (Anti-CXCL10 / IP-10)
ABT-494(Upadacitinib) Free base
Olcegepant (Synonyms: BIBN-4096; BIBN 4096BS)
Ritlecitinib Tosylate
Reticuline
Afuresertib-F free base | Afuresertib-F free base | GSK-2110183-analog 1